Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

Hormones Regulating Blood Glucose

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

Overview of Carbohydrate Metabolism

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1.

Journal of child neurology·2013

Same author

Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH.

Cell metabolism·2013

Same author

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

Epilepsia·2011

Same author

A ketogenic diet does not impair rat behavior or long-term potentiation.

Epilepsia·2010

Same author

A physiological role for amyloid-beta protein:enhancement of learning and memory.

Journal of Alzheimer's disease : JAD·2009

Same author

FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons.

Neurobiology of disease·2008

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Calorie restriction and glucose regulation.

Kelvin A Yamada¹

¹Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. yamadak@wustl.edu

|December 17, 2008

Summary

Ketogenic diets (KDs) effectively treat epilepsy by influencing energy regulation pathways. This review explores how calorie restriction, low glucose, and KDs may reduce brain excitability via AMP-activated protein kinase (AMPK).

Area of Science:

Neuroscience
Metabolic disorders
Biochemistry

Background:

Ketogenic diets (KDs) are established epilepsy treatments, but their mechanisms remain unclear.
Evidence suggests calorie restriction and hypoglycemia enhance KD antiseizure effects.
Interactions between energy metabolism and anticonvulsant actions are indicated by glycolysis inhibition reducing seizures.

Purpose of the Study:

To explore shared cell signaling pathways linking energy regulation and anticonvulsant actions of KDs.
To investigate the role of AMP-activated protein kinase (AMPK) in mediating KD effects on brain excitability.

Main Methods:

Review of existing literature on ketogenic diets, epilepsy, energy metabolism, and cell signaling.
Analysis of experimental seizure models and clinical observations in children and rodents on KDs.

More Related Videos

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Related Experiment Videos

Last Updated: Jun 27, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

Consideration of metabolic and hormonal changes associated with KDs, including weight, glucose, insulin, and leptin levels.

Main Results:

Ketogenic diets are associated with poor weight gain, lower blood glucose, and altered insulin and leptin levels in children and rodents.
Calorie restriction and hypoglycemia may augment KD antiseizure effects.
Inhibition of glycolysis shows potential in reducing seizures and epileptogenesis.

Conclusions:

Common cell signaling pathways likely link energy regulation strategies (calorie restriction, low glucose, KDs) to altered brain excitability.
AMP-activated protein kinase (AMPK) is a plausible signaling molecule connecting energy balance to gene expression for reduced brain excitability.
Further research is warranted to elucidate the precise molecular mechanisms underlying KD efficacy in epilepsy.